Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Templeman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Issues in Molecular Biology|January 22, 2024
Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix<sup>®</sup> SystemGabrielle Wishart, Amy Templeman, Francesca Hendry, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2014
P3 SAR exploration of biphenyl carbamate based Legumain inhibitorsCatherine Higgins, Samira Bouazzaoui, Kishore Gaddale, et al.
Nucleic Acids Research|June 10, 2022
TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancersAlexander J McIntyre, Charlotte Z Angel, James S Smith, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Journal of Circulating Biomarkers|August 21, 2023
Analytical performance of the FDA-cleared Parsortix<sup>®</sup> PC1 systemAmy Templeman, M Craig Miller, Martin J Cooke, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Issues in Molecular Biology|January 22, 2024
Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix<sup>®</sup> SystemGabrielle Wishart, Amy Templeman, Francesca Hendry, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2014
P3 SAR exploration of biphenyl carbamate based Legumain inhibitorsCatherine Higgins, Samira Bouazzaoui, Kishore Gaddale, et al.
Nucleic Acids Research|June 10, 2022
TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancersAlexander J McIntyre, Charlotte Z Angel, James S Smith, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Journal of Circulating Biomarkers|August 21, 2023
Analytical performance of the FDA-cleared Parsortix<sup>®</sup> PC1 systemAmy Templeman, M Craig Miller, Martin J Cooke, et al.
Pageof 1